The mission of St. Jude Children’s Research Hospital is “to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment.” The Pharmaceutical Department at St. Jude contributes to this unique institutional commitment by providing advanced practice pharmaceutical services that individualize care for each child at St. Jude while supporting a collective research endeavor.
St. Jude Children’s Research Hospital offers three different ASHP-accredited 12-month specialized pharmacy residency (PGY2) opportunities. PGY2 training opportunities include Oncology - Pediatrics, Clinical Pharmacogenetics and Medication-Use Safety.
The PGY2 residents in the individual programs have the opportunity to learn, contribute, and participate in a dynamic environment that consists of professional and technical personnel in both patient care and pharmaceutical research. Oncology and Clinical Pharmacogenetics residents receive training in applied pharmacokinetics, nutrition support, and advanced training in clinical therapeutics of the pediatric cancer patient, pharmacogenetics, and medication-use safety. Medication-Use Safety residents are provided advanced training in medication safety and medication-use policy.
Depending on the residency program, the resident will have the opportunity to: participate in direct patient care responsibilities, precept Doctor of Pharmacy students, provide didactic lectures, in-services and journal clubs, and participate in Pharmacy and Therapeutics committee meetings, as well as conduct collaborative clinical research. Residents will be expected to develop and complete a research project during the year and present their findings at a national meeting.